Convergent validity and effect of instruction modification on the groton maze learning test: a new measure of spatial working memory and error monitoring.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 19922344)

Published in Int J Neurosci on January 01, 2009

Authors

Robert H Pietrzak1, Paul Maruff, Peter J Snyder

Author Affiliations

1: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. rhpietrzak@gmail.com

Articles by these authors

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol (2013) 5.73

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85

The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc (2003) 2.83

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr (2009) 2.54

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol (2004) 2.49

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab (2004) 2.35

Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directions. Alzheimers Dement (2009) 2.30

Determining the extent of cognitive change after coronary surgery: a review of statistical procedures. Ann Thorac Surg (2002) 2.17

Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol (2006) 1.92

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn (2005) 1.91

CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med (2003) 1.76

Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res (2005) 1.67

Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol (2004) 1.59

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology (2006) 1.56

The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg (2011) 1.55

Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. BMC Bioinformatics (2014) 1.53

The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. Int J Neuropsychopharmacol (2012) 1.52

Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery. Ann Thorac Surg (2009) 1.50

Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology (2015) 1.50

The influence of different error estimates in the detection of postoperative cognitive dysfunction using reliable change indices with correction for practice effects. Arch Clin Neuropsychol (2007) 1.47

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46

In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol. J Bone Miner Res (2008) 1.45

Outcomes and costs of acute treatment of traumatic brain injury. J Trauma (2002) 1.44

Differences in motor imagery between children with developmental coordination disorder with and without the combined type of ADHD. Dev Med Child Neurol (2008) 1.40

In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res (2008) 1.40

Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev (2006) 1.37

Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab (2003) 1.36

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology (2012) 1.31

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain (2013) 1.31

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29

Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg (2011) 1.27

The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol (2005) 1.26

Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res (2007) 1.26

Natural history of concussion in sport: markers of severity and implications for management. Am J Sports Med (2010) 1.26

Assessing cognitive function in cancer patients. Support Care Cancer (2006) 1.25

Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res (2008) 1.24

Role of magnetic resonance for assessing structure and function of trabecular bone. Top Magn Reson Imaging (2002) 1.23

Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%. J Sleep Res (2003) 1.22

Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol (2012) 1.18

Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology (2002) 1.17

A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J Clin Exp Neuropsychol (2009) 1.17

Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging. Neuroimage (2008) 1.15

Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res (2003) 1.15

Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Ann Neurol (2013) 1.13

Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease. Alzheimers Dement (2007) 1.12

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis. J Int Neuropsychol Soc (2006) 1.11

The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology (2006) 1.11

Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biol Psychiatry (2002) 1.10

An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring. Arch Clin Neuropsychol (2008) 1.09

Contagious yawning in autistic and typical development. Child Dev (2010) 1.07

Voice acoustic measures of depression severity and treatment response collected via interactive voice response (IVR) technology. J Neurolinguistics (2007) 1.07

Spatio-visual memory of children with specific language impairment: evidence for generalized processing problems. Int J Lang Commun Disord (2005) 1.07

Development of a statistical approach to classifying treatment response in individual children with ADHD. Hum Psychopharmacol (2004) 1.06

Behavioral characterization of mild cognitive impairment. J Clin Exp Neuropsychol (2002) 1.06

A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res (2005) 1.06

Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study. Contemp Clin Trials (2006) 1.05

Recruitment challenges of a multicenter randomized controlled varicocelectomy trial. Fertil Steril (2011) 1.05

Mechanical implications of estrogen supplementation in early postmenopausal women. J Bone Miner Res (2010) 1.04

Spectrum of saccade system function in Alzheimer disease. Arch Neurol (2003) 1.03

Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg (2009) 1.02

Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities. Drug Alcohol Rev (2004) 1.01

Episodic memory decline predicts cortical amyloid status in community-dwelling older adults. J Alzheimers Dis (2011) 1.00

Impaired performance of children exposed in utero to cocaine on a novel test of visuospatial working memory. Brain Cogn (2004) 1.00

Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement (2012) 1.00

Perception of alcohol intoxication shows acute tolerance while executive functions remain impaired. Exp Clin Psychopharmacol (2010) 0.99

Voice acoustical measurement of the severity of major depression. Brain Cogn (2004) 0.99

Anterior cingulate activation during Stroop task performance: a PET to MRI coregistration study of individual patients with schizophrenia. Am J Psychiatry (2002) 0.98

A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Hum Psychopharmacol (2005) 0.98

Rapid decline in episodic memory in healthy older adults with high amyloid-β. J Alzheimers Dis (2013) 0.97

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement (2011) 0.97

Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. J Alzheimers Dis (2013) 0.96

Repeated assessment of cognition in children and the measurement of performance change. Child Neuropsychol (2005) 0.95

Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery (2005) 0.95

BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiol Aging (2013) 0.95

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95

Attention, motor control and motor imagery in schizophrenia: implications for the role of the parietal cortex. Schizophr Res (2004) 0.95

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension. Eur Neuropsychopharmacol (2013) 0.95

Assessment of cognition in early dementia. Alzheimers Dement (2011) 0.94

Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: a longitudinal case study. Brain Cogn (2004) 0.94

Cognitive impairment in Aboriginal people with heavy episodic patterns of alcohol use. Addiction (2007) 0.94

Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Arch Clin Neuropsychol (2013) 0.93

The neurobehavioural effects of kava. Aust N Z J Psychiatry (2002) 0.93

Preexisting cognitive impairment and mild cognitive impairment in subjects presenting for total hip joint replacement. Anesthesiology (2011) 0.93

HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatry Clin Neurosci (2011) 0.92

Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab (2014) 0.92

Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia. PLoS One (2011) 0.92